Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Meuleman

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
BJA Open|June 8, 2026
Assessing ultraviolet-C light-emitting diode disinfection of disposable video laryngoscope blades: a sustainable approach through an integrated microbiological, environmental, economic, and regulatory evaluationHannah Siwe, Bjorn Delbeecke, Piet Cools, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 11, 2009
The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dioneLeen Lootens, Peter Van Eenoo, Philip Meuleman, et al.
Hepatology (Baltimore, Md.)|July 16, 2015
Is hepatitis E virus an emerging problem in industrialized countries?Ibrahim M Sayed, Ann-Sofie Vercouter, Sayed F Abdelwahab, et al.
Gastroenterology|October 9, 2007
Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouseThomas Vanwolleghem, Philip Meuleman, Louis Libbrecht, et al.
Hepatology (Baltimore, Md.)|November 26, 2008
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivoPhilip Meuleman, Joseph Hesselgesser, Matthew Paulson, et al.
The Journal of Infectious Diseases|April 20, 2019
Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV DiagnosisIbrahim M Sayed, Lieven Verhoye, Claire Montpellier, et al.
Journal of Hepatology|July 2, 2010
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID miceThomas Vanwolleghem, Louis Libbrecht, Bettina E Hansen, et al.
Clinical Chemistry|August 1, 2009
uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case studyLeen Lootens, Philip Meuleman, Oscar J Pozo, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
Successful Engraftment of Human Hepatocytes in uPA-SCID and FRG<sup>®</sup> KO MiceLander Foquet, Elizabeth M Wilson, Lieven Verhoye, et al.
Viruses|December 23, 2023
Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid AssaysLaura Corneillie, Irma Lemmens, Karin Weening, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
BJA Open|June 8, 2026
Assessing ultraviolet-C light-emitting diode disinfection of disposable video laryngoscope blades: a sustainable approach through an integrated microbiological, environmental, economic, and regulatory evaluationHannah Siwe, Bjorn Delbeecke, Piet Cools, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 11, 2009
The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dioneLeen Lootens, Peter Van Eenoo, Philip Meuleman, et al.
Hepatology (Baltimore, Md.)|July 16, 2015
Is hepatitis E virus an emerging problem in industrialized countries?Ibrahim M Sayed, Ann-Sofie Vercouter, Sayed F Abdelwahab, et al.
Gastroenterology|October 9, 2007
Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouseThomas Vanwolleghem, Philip Meuleman, Louis Libbrecht, et al.
Hepatology (Baltimore, Md.)|November 26, 2008
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivoPhilip Meuleman, Joseph Hesselgesser, Matthew Paulson, et al.
The Journal of Infectious Diseases|April 20, 2019
Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV DiagnosisIbrahim M Sayed, Lieven Verhoye, Claire Montpellier, et al.
Journal of Hepatology|July 2, 2010
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID miceThomas Vanwolleghem, Louis Libbrecht, Bettina E Hansen, et al.
Clinical Chemistry|August 1, 2009
uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case studyLeen Lootens, Philip Meuleman, Oscar J Pozo, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
Successful Engraftment of Human Hepatocytes in uPA-SCID and FRG<sup>®</sup> KO MiceLander Foquet, Elizabeth M Wilson, Lieven Verhoye, et al.
Viruses|December 23, 2023
Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid AssaysLaura Corneillie, Irma Lemmens, Karin Weening, et al.
Pageof 13